4
Views
0
CrossRef citations to date
0
Altmetric
Articles

Absolute neutrophil counts and fibrinogen levels as an aid in the early diagnosis of acute myocardial infarction

, , , , , & show all
Pages 135-140 | Received 03 Mar 2003, Accepted 26 Aug 2003, Published online: 23 May 2017

References

  • Lee TH, Goldman L. Evaluation of the patient with acute chest pain. NEJM 2000; 342: 1187–95.
  • Capewell S, McMurray J. “Chest-pain - please admit”: is there an alternative? Br Med J2000; 320: 951–2.
  • Kendrick S, Frame S, Povey C. Beds occupied by emer-gency patients: long-term trends in patterns of short-term fluctuation in Scotland. Health Bull (Edinb) 1997; 55: 167–75.
  • Blatchford O, Capewell S. Emergency medical admission in Glasgow: general practices vary despite adjustment for age, sex and deprivation. Br J Gen Pract 1999; 49: 551–4.
  • Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115–26.
  • Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hen-nekens CH. Inflammation, aspirin, and the risk of cardio-vascular disease in apparently healthy men [published erra-tum appears in N Engl J Med 1997; 337: 356]. N Engl J Med 1997; 336: 973–9.
  • Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Cir-culation 1998; 98: 731–3.
  • Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein lev-els in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Cir-culation 1997; 96: 4204–10.
  • Van Lente F. Markers of inflammation as predictors in car-diovascular disease. Clin Chim Acta 2000; 293: 31–52.
  • Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical out-comes in the setting of acute myocardial infarction: a throm-bolysis in myocardial infarction 10 substudy. Circulation 2000; 102: 2329–34.
  • National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intoler-ance. Diabetes 1979; 28: 1039–57.
  • The fifth report of the Joint National Committee on Detec-tion, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154–83.
  • WHO memorandum. Classification of hyperlipidemias and hyperlipoproteinemias. Circulation 1972; 45: 501–8.
  • Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502–13.
  • Braunwald E, Antman EM, Beasley JW, Calif RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kuper-smith J, Levin TN, Pepine CJ, Schaeffer JAV, Smith EE 3rd, Steward DE, Theroux P, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC Jr. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocar-dial infarction. A report of the American College of Cardi-ology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000; 36: 970–1062.
  • Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O’Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk for ischemic heart disease: the Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836–44.
  • Lowe GD, Machado SG, Krol WF, Barton BA, Forbes CD. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 1985; 54: 700–3.
  • Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Braunwald E, Gibson CM. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy-Throm-bolysis in Myocardial Infarction 18 trial) substudy. JACC 2002; 40: 1761–8.
  • Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dor-mandy JA. Leukocytes and the risk of ischemic diseases. JAMA 1987; 257: 2318–24.
  • Burr ML, Holliday RM, Fehily AM, Whitehead PJ. Haema-tological prognostic indices after myocardial infarction: from the Diet and Reinfarction Trial (DART). Eur Heart J1992; 13: 166–70.
  • Furman MI, Becker RC, Yarzebski J, Savegeau J, Gore JM, Goldberg RJ. Effect of elevated leukocyte count on in-hos-pital mortality following acute myocardial infarction. Am J Cardiol 1996; 78: 945–8.
  • Ott I, Neumann FJ, Kenngott S, Gawaz M, Schomig A. Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cardiol 1998; 82: 938–42.
  • Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 1994; 105: 897–904.
  • Marx N, Neumann FJ, Ott I, Gawaz M, Koch W, Pinkau T, Schomig A. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol 1997; 30: 165–70.
  • Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schomig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995; 92: 748–55.
  • Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schoemig A. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulantactivity. Arterioscler Thromb Vasc Biol 1997; 17: 3399–405.
  • Ferroni P, Basili S, Alessandri C, Vieri M, Martini F, Belogi A, Pulcinelli FM, Cordova C, Gazzaniga PP. Proinflamma-tory cytokines and haemostatic system in patients with chronic obstructive pulmonary disease. Platelets 1997; 8: 255–9.
  • Libby P, Simon DI. Inflammation and thrombosis. Circula-tion 2001; 103: 1718–20.
  • Wong CK, French JK, Gao W, Withe HD. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and inci-dence of thrombolysis in myocardial infarction-3 flow after streptokinase. Am Heart J 2003; 145: 95–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.